Best Practices in Fragile X Syndrome Treatment Development

Preclinical studies using animal models of fragile X syndrome have yielded several agents that rescue a wide variety of phenotypes. However, translation of these treatments to humans with the disorder has not yet been successful, shedding light on a variety of limitations with both animal models and...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Craig A., Kaufmann, Walter E., Budimirovic, Dejan B., Lachiewicz, Ave, Haas-Givler, Barbara, Miller, Robert M., Weber, Jayne Dixon, Abbeduto, Leonard, Hessl, David, Hagerman, Randi J., Berry-Kravis, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315698/
https://www.ncbi.nlm.nih.gov/pubmed/30558274
http://dx.doi.org/10.3390/brainsci8120224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315698/
https://www.ncbi.nlm.nih.gov/pubmed/30558274
http://dx.doi.org/10.3390/brainsci8120224

Ejemplares similares